183 related articles for article (PubMed ID: 19803555)
1. Sensitivity of administrative claims to identify incident cases of lung cancer: a comparison of 3 health plans.
Ramsey SD; Scoggins JF; Blough DK; McDermott CL; Reyes CM
J Manag Care Pharm; 2009 Oct; 15(8):659-68. PubMed ID: 19803555
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Comorbid Medical Conditions in the National Cancer Database and the SEER-Medicare Database.
Lin CC; Virgo KS; Robbins AS; Jemal A; Ward EM
Ann Surg Oncol; 2016 Dec; 23(13):4139-4148. PubMed ID: 27535406
[TBL] [Abstract][Full Text] [Related]
3. Limited validity of diagnosis codes in Medicare claims for identifying cancer metastases and inferring stage.
Chawla N; Yabroff KR; Mariotto A; McNeel TS; Schrag D; Warren JL
Ann Epidemiol; 2014 Sep; 24(9):666-72, 672.e1-2. PubMed ID: 25066409
[TBL] [Abstract][Full Text] [Related]
4. Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancer.
Onukwugha E; Yong C; Hussain A; Seal B; Mullins CD
BMC Med Res Methodol; 2014 Jan; 14():1. PubMed ID: 24383436
[TBL] [Abstract][Full Text] [Related]
5. Utility of administrative claims data for the study of brain metastases: a validation study.
Eichler AF; Lamont EB
J Neurooncol; 2009 Dec; 95(3):427-431. PubMed ID: 19562256
[TBL] [Abstract][Full Text] [Related]
6. Healthcare utilization and costs associated with COPD among SEER-Medicare beneficiaries with NSCLC.
Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
J Med Econ; 2018 Sep; 21(9):861-868. PubMed ID: 29857784
[TBL] [Abstract][Full Text] [Related]
7. Administrative and claims records as sources of health care cost data.
Riley GF
Med Care; 2009 Jul; 47(7 Suppl 1):S51-5. PubMed ID: 19536019
[TBL] [Abstract][Full Text] [Related]
8. Validation of body mass index (BMI)-related ICD-9-CM and ICD-10-CM administrative diagnosis codes recorded in US claims data.
Ammann EM; Kalsekar I; Yoo A; Johnston SS
Pharmacoepidemiol Drug Saf; 2018 Oct; 27(10):1092-1100. PubMed ID: 30003617
[TBL] [Abstract][Full Text] [Related]
9. Greater Spending Associated with Improved Survival for Some Cancers in OCM-Defined Episodes.
Baumgardner J; Shahabi A; Linthicum M; Vine S; Zacker C; Lakdawalla D
J Manag Care Spec Pharm; 2018 Jun; 24(6):504-513. PubMed ID: 29799330
[TBL] [Abstract][Full Text] [Related]
10. Agreement of Medicare claims and tumor registry data for assessment of cancer-related treatment.
Cooper GS; Yuan Z; Stange KC; Dennis LK; Amini SB; Rimm AA
Med Care; 2000 Apr; 38(4):411-21. PubMed ID: 10752973
[TBL] [Abstract][Full Text] [Related]
11. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.
Blanchette CM; Gutierrez B; Ory C; Chang E; Akazawa M
J Manag Care Pharm; 2008 Mar; 14(2):176-85. PubMed ID: 18331119
[TBL] [Abstract][Full Text] [Related]
12. Neutropenia-related costs in patients treated with first-line chemotherapy for advanced non-small cell lung cancer.
Stokes ME; Muehlenbein CE; Marciniak MD; Faries DE; Motabar S; Gillespie TW; Lipscomb J; Knopf KB; Buesching DP
J Manag Care Pharm; 2009 Oct; 15(8):669-82. PubMed ID: 19803556
[TBL] [Abstract][Full Text] [Related]
13. Trends in US Ambulatory Care Patterns During the COVID-19 Pandemic, 2019-2021.
Mafi JN; Craff M; Vangala S; Pu T; Skinner D; Tabatabai-Yazdi C; Nelson A; Reid R; Agniel D; Tseng CH; Sarkisian C; Damberg CL; Kahn KL
JAMA; 2022 Jan; 327(3):237-247. PubMed ID: 35040886
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of three algorithms to identify incident breast cancer in Medicare claims data.
Gold HT; Do HT
Health Serv Res; 2007 Oct; 42(5):2056-69. PubMed ID: 17850533
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of coding algorithms to identify patients with incident lung cancer in United States healthcare claims data.
Beyrer J; Nelson DR; Sheffield KM; Huang YJ; Ellington T; Hincapie AL
Pharmacoepidemiol Drug Saf; 2020 Nov; 29(11):1465-1479. PubMed ID: 33012044
[TBL] [Abstract][Full Text] [Related]
16. Assessing functional status and the survival benefit of chemotherapy for advanced non-small cell lung cancer using administrative claims data.
Feliciano J; Gardner L; Hendrick F; Edelman MJ; Davidoff A
Lung Cancer; 2015 Jan; 87(1):59-64. PubMed ID: 25443272
[TBL] [Abstract][Full Text] [Related]
17. Identifying Medicare Beneficiaries Accessing Transgender-Related Care in the Era of ICD-10.
Ewald ER; Guerino P; Dragon C; Laffan AM; Goldstein Z; Streed C
LGBT Health; 2019; 6(4):166-173. PubMed ID: 31084519
[No Abstract] [Full Text] [Related]
18. Race and sex differences in the receipt of timely and appropriate lung cancer treatment.
Shugarman LR; Mack K; Sorbero ME; Tian H; Jain AK; Ashwood JS; Asch SM
Med Care; 2009 Jul; 47(7):774-81. PubMed ID: 19536007
[TBL] [Abstract][Full Text] [Related]
19. Construct validity of medicare chemotherapy claims: the case of 5FU.
Lamont EB; Lauderdale DS; Schilsky RL; Christakis NA
Med Care; 2002 Mar; 40(3):201-11. PubMed ID: 11880793
[TBL] [Abstract][Full Text] [Related]
20. Using administrative data to study persons with disabilities.
Iezzoni LI
Milbank Q; 2002; 80(2):347-79. PubMed ID: 12101876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]